Ensysce Biosciences's market cap is currently ―. The company's EPS TTM is $-138.7; its P/E ratio is -0.01; Ensysce Biosciences is scheduled to report earnings on November 13, 2023, and the estimated EPS forecast is $-1.06. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 490.47K	$ 789.63K	$ 1.43M	$ 0.00	$ 0.00
Gross Profit	$ 490.47K	$ 789.63K	$ 2.75M	-	-
EBIT	$ -2.24M	$ 4.15M	$ -6.23M	$ -9.85M	$ -7.89M
EBITDA	$ -2.24M	$ 4.15M	$ -6.23M	$ -9.85M	$ -7.89M
Net Income Common Stockholders	$ -2.24M	$ 4.51M	$ -5.52M	$ -9.90M	$ -8.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.83M	$ 1.42M	$ 3.15M	$ 4.50M	$ 3.73M
Total Assets	$ 6.36M	$ 3.91M	$ 5.89M	$ 8.29M	$ 7.95M
Total Debt	$ 456.66K	$ 19.12K	$ 4.74M	$ 8.98M	$ 2.67M
Net Debt	$ -3.37M	$ -1.40M	$ 1.60M	$ 4.47M	$ -1.07M
Total Liabilities	$ 2.56M	$ 4.07M	$ 9.91M	$ 14.71M	$ 8.75M
Stockholders Equity	$ 4.08M	$ 166.72K	$ -3.71M	$ -6.09M	$ -491.64K
Cash Flow	-
Free Cash Flow	$ -3.11M	$ -3.61M	$ -3.30M	$ -6.71M	$ -4.44M
Operating Cash Flow	$ -3.11M	$ -3.61M	$ -3.30M	$ -6.71M	$ -4.44M
Investing Cash Flow	-	-	-	$ 0.00	$ 0.00
Financing Cash Flow	$ 5.52M	$ 1.87M	$ 1.94M	$ 7.48M	$ -265.81K

Currency in USD

Ensysce Biosciences Earnings and Revenue History

Income Statement >

Ensysce Biosciences Debt to Assets

Balance Sheet >

Ensysce Biosciences Cash Flow

Cash Flow >

Ensysce Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing